您当前位置：首页 > 国际期刊-CANCER IMMUNOLOGY IMMUNOTHERAPY期刊投稿发表详细信息

CANCER IMMUNOLOGY IMMUNOTHERAPY Q1

期刊收录：
SCIE
Scopus

基本信息

期刊ISSN：
0340-7004
期刊简拼：
CANCER IMMUNOL IMMUN
年发文章数：
207
E-ISSN：
1432-0851
Gold OA文章占比
37.71%
研究文章占比：
90.82%
是否OA：
No
Jcr分区：
Q1
中科院分区：
2区

出版信息

出版商：
Springer Berlin Heidelberg
涉及研究方向：
医学-免疫学
出版国家：
UNITED STATES
出版语言：
English
出版周期：
Monthly
出版年份：
1976

2023-2024最新影响因子:4.6
自引率:0.00%
五年影响因子:5.4
JCI期刊引文指标:1.01
h-index:104
CiteScore:10.50

期刊关键词

1区 SCIE Scopus 医学 2区 IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学

期刊简介

Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.

The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.

《CANCER IMMUNOLOGY IMMUNOTHERAPY》期刊已被查看：次
期刊简写：CANCER IMMUNOL IMMUN

此期刊被最新的JCR期刊SCIE收录